The Neurobiology of Neurotensin

  • Peter J. Elliott
  • Charles B. Nemeroff
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


This chapter summarizes the available data supporting a neuroregulatory role for neurotensin (NT) in the mammalian central nervous system (CNS). The major focus is on effects of centrally administered NT, and a secondary focus is the possible importance of this peptide in the pathophysiology of schizophrenia and in the mechanism of action of antipsychotic drugs.


Nucleus Accumbens Ventral Tegmental Area Neurotensin Receptor Central Amygdaloid Nucleus Central Nervous System Area 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agnati, L. F., Fuxe, K., Benfenati, F., and Battistini, N., 1983, Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites, Acta Physiol. Scand. 119:459–461.PubMedCrossRefGoogle Scholar
  2. Anderson, C. M., Bissette, G., Nemeroff, C. B., and Kilts, C. D., 1984, Microtopographic distribution of neurotensin and catecholamine concentrations at the level of individual rat brain nuclei, Soc. Neurosci. Abstr. 10:437.Google Scholar
  3. Andrade, R., and Aghajanian, G. K., 1981, Neurotensin selectively activates dopamine neurons in the substantia nigra, Soc. Neurosci. Abstr. 7:573.Google Scholar
  4. Araki, K., Tachibana, S., Uchiyama, M., Nakajima, T., and Yasuhara, T., 1973, Isolation and structure of a new active peptide “xenopsin” on the smooth muscle, especially on a strip of fundus from a rat stomach, from the skin of Xenopus laevis, Chem. Pharm. Bull. 21:2801–2804.PubMedCrossRefGoogle Scholar
  5. Beitz, A. J., 1982, The sites of origin of brain stem neurotensin and serotonin projections to the rodent nucleus raphe magnus, J. Neurosci. 2:829–842.PubMedGoogle Scholar
  6. Bentall, A. C. C., and Herberg, L. J., 1980, Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic thioridazine, Neuropharmacology 19:699–703.PubMedCrossRefGoogle Scholar
  7. Bhatnagar, Y. M., and Carraway, R., 1981, Bacterial peptides with C-terminal similarities to bovine neurotensin, Peptides 2:51–59.PubMedCrossRefGoogle Scholar
  8. Bissette, G., Nemeroff, C. B., Loosen, P. T., Prange, A. J., Jr., and Lipton, M. A., 1976, Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin, Nature 262:607–609.PubMedCrossRefGoogle Scholar
  9. Bissette, G., Nemeroff, C. B., Loosen, P. T., Breese, G. R., Burnett, G. B., Lipton, M. A., and Prange, A. J., Jr., 1978, Modification of pentobarbital-induced sedation by natural and synthetic peptides, Neuropharmacology 17:229–237.PubMedCrossRefGoogle Scholar
  10. Bissette, G., Luttinger, D., Nemeroff, C. B., and Prange, A. J., Jr., 1981, The effects of d-amphetamine, methylphenidate, and apomorphine on neurotensin-induced hypothermia in mice, Soc. Neurosci. Abstr. 7:32.Google Scholar
  11. Bissette, G., Jennes, L., Prange, A. J., Jr., Breese, G. R., and Nemeroff, C. B., 1983, Neurotensin and dopamine are not co-localized in rat brain, Soc. Neurosci. Abstr. 9:290.Google Scholar
  12. Bissette, G., Richardson, C., Kizer, J. S., and Nemeroff, C. B., 1984, Ontogeny of brain neurotensin in the rat: A radioimmunoassay study, J. Neurochem. 43:283–287.PubMedCrossRefGoogle Scholar
  13. Bissette, G., Nemeroff, C. B., Decker, M. W., Kizer, J. S., Agid, Y., and Javoy-Agid, F., 1985, Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson’s disease, Ann. Neurol. 17:324–329.PubMedCrossRefGoogle Scholar
  14. Blackburn, A. M., and Bloom, S. R., 1979, A radioimmunoassay for neurotensin in human plasma, J. Endocrinol. 83:175–181.PubMedCrossRefGoogle Scholar
  15. Bloom, S. R., and Polak, J. M., 1982, Aspects of neurotensin physiology and pathology, Ann. N.Y. Acad. Sci. 400:105–116.PubMedCrossRefGoogle Scholar
  16. Brown, M. R., and Vale, W., 1980, Peptides and thermoregulation, in: Thermoregulatory Mechanisms and Their Therapeutic Implication (B. Cox, P. Lomax, A. S. Milton, and E. Schonbaum, eds.), pp. 186–194, S. Karger, Basel.Google Scholar
  17. Brown, M., Rivier, J., and Vale, W., 1977, Bombesin: Potent effects on thermoregulation in the rat, Science 196:998–1000.PubMedCrossRefGoogle Scholar
  18. Bueno, L., Ferre, J. P., Fioramonti, J., and Honde, C., 1983, Effects of intracerebroventricular administration of neurotensin, substance P and calcitonin on gastrointestinal motility in normal and vagotomized rats, Regul. Peptides 6:197–205.CrossRefGoogle Scholar
  19. Burgess, S. K., Luttinger, D. E., Hernandez, D., Kalivas, P. W., Nemeroff, C. B., and Prange, A. J., Jr., 1983, Antogonism of the central nervous system effects of neurotensin by thyrotropin-releasing hormone, in: Thyrotropin-Releasing Hormone (E. C. Griffiths and G. W. Bennett, eds.), pp. 291–302, Raven Press, New York.Google Scholar
  20. Camargo, A. C. M., Caldo, H., and Emson, P. C., 1983, Degradation of neurotensin by rabbit brain endo-oligopeptidase A and endo-oligopeptidase B, Biochem. Biophys. Res. Commun. 116:1151–1159.PubMedCrossRefGoogle Scholar
  21. Carraway, R. E., 1982, A critical analysis of three approaches to radioimmunoassay of peptides: Applications to the study of the neurotensin family, Ann. N.Y. Acad. Sci. 400:17–36.PubMedCrossRefGoogle Scholar
  22. Carraway, R., and Leeman, S. E., 1973, The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami, J. Biol. Chem. 250:1907–1911.Google Scholar
  23. Carraway, R. E., and Leeman, S. E., 1975, The amino acid sequence of a hypothalamic peptide, neurotensin, J. Biol. Chem. 250:1907–1911.PubMedGoogle Scholar
  24. Carraway, R., and Leeman, S. E., 1976, Characterization of radioimmunoassayable neurotensin in the rat: Its differential distribution in the central nervous system, small intestine, and stomach, J. Biol. Chem. 251:7045–7052.PubMedGoogle Scholar
  25. Carraway, R., Ruane, S. E., and Kim, H. R., 1982, Distribution and immunochemical character of neurotensin-like material in representative vertebrates and invertebrates: Apparent conservation of the COOH-terminal region during evolution, Peptides 3:115–123.PubMedCrossRefGoogle Scholar
  26. Chandra, A., Chov, H. C., Chang, C., and Lin, M. T., 1981, Effects if intraventricular administration and somatostatin on thermoregulation in the rat, Neuopharmacology 20:715–718.CrossRefGoogle Scholar
  27. Checler, F., Kitabgi, P., and Vincent, J. P., 1982, Degradation of neurotensin by brain synaptic membranes, Ann. N.Y. Acad. Sci. 400:413–414.CrossRefGoogle Scholar
  28. Checler, F., Vincent, J. P., and Kitabgi, P., 1983, Neurotensin analogs [D-Tyr11] and [D-Phe11] neurotensin resist degradation by brain peptidases in vitro and in vivo, J. Pharmacol. Exp. Ther. 227:743–7PubMedGoogle Scholar
  29. Clark, W. G., 1979, Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents, Neurosci. Biobehav. Res. 3:179–231.CrossRefGoogle Scholar
  30. Clineschmidt, B. V., and McGuffin, J. C., 1977, Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli, Eur. J. Pharmacol. 46:395–396.PubMedCrossRefGoogle Scholar
  31. Clineschmit, B.V., McGuffin, J.C., and Bunting, P. B., 1979, Neurotensin: Antinocisponsive action in rodents, Eur. J. Pharmacol. 54:129–139.CrossRefGoogle Scholar
  32. Clineschmidt, B. V., Martin, G. E., and Veber, D. F., 1982, Antinocisponsive effects of neurotensin and neurotensin-related peptides, Ann. N.Y. Acad. Sci. 400:283–306.PubMedCrossRefGoogle Scholar
  33. Cooper, P. E., Fernstrom, M. H., Rorstad, O. P., Leeman, S. E., and Martin, J. B., 1981, The regional distribution of somatostain, substance P and neurotensin in human brain, Brain Res. 218:219–232.PubMedCrossRefGoogle Scholar
  34. Costall, B., and Naylor, R. J., 1976, A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride, and metaclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems, Eur. J. Pharmacol. 40:9–19.PubMedCrossRefGoogle Scholar
  35. Courvoisier, S., 1956, Pharmacodynamic basis for the use of chlorpromazine in psychiatry, J. Clin. Exp. Psychopathol. 17:25–37.PubMedGoogle Scholar
  36. Cowan, A., and Gmerek, D. E., 1981, Studies on the antinocisponsive action of neurotensin, Fed. Proc. 40:273.Google Scholar
  37. Cowan, A., and Gmerek, D. E., 1982, Defining the antinociceptive actions of neurotensin, Ann. N.Y. Acad. Sci. 400:438–439.CrossRefGoogle Scholar
  38. Dahlstrom, A., and Fuxe, K., 1964, Evidence for the existence of monoamine containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons, Acta Physiol. Scand. 62:1–55.Google Scholar
  39. DeQuidt, M., and Emson, P. C., 1983, Neurotensin facilitates dopamine release in vitro from rat striatal slices, Brain Res. 274:376–380.CrossRefGoogle Scholar
  40. Dupont, A., and Merand, Y., 1978, Enzymic inactivation of neurotensin by hypothalamic and brain extracts of the rat, Life Sci. 22:1623–1630.PubMedCrossRefGoogle Scholar
  41. Dupont, A., Largelier, P., Merand, Y., Cote, J., and Barden, N., 1979, Radioimmunoassay studies of the regional distribution of neurotensin, substance P, somatostatin, thyrotropin, corticotropin, Lys-vasopressin, and opiate peptides in bovine brain, in: Proceedings of the Endocrine Society 61st Annual Meeting, p. 127, Endocrine Society, Washington, D.C.Google Scholar
  42. Eldred, W. D., and Karten, H. J., 1983, Characterization and quantification of peptidergic amacrine cells in the turtle retina: Enkephalin, neurotensin and glucagon, J. Comp. Neurol. 221:371–381.PubMedCrossRefGoogle Scholar
  43. Emson, P. C., Goedert, M., Williams, B., Ninkovic, N., and Hunt, S. P., 1982a, Neurotensin: Regional distribution, characterization and inactivation, Ann. N.Y. Acad. Sci. 400:198–215.PubMedCrossRefGoogle Scholar
  44. Emson, P. C., Goedert, M., Benton, H., St. Pierre, S., and Rioux, F., 1982b, The regional distribution and Chromatographie characterization of neurotensin-like immunoreactivity in the rat, Adv. Biochem. Psychopharmacol. 33:477–487.PubMedGoogle Scholar
  45. Emson, P. C., Goedert, M., Horsfield, P., Rioux, F., and St. Pierre, S., 1982c, The regional distribution and Chromatographie characterization of neurotensin-like immunoreactivity in the rat central nervous system, J. Neurochem. 38:992–999.PubMedCrossRefGoogle Scholar
  46. Emson, P. C., Goedert, M., and Mantyh, P. W., 1985a, Neurotensin-containing neurons, in: Handbook of Chemical Neuroanatomy, Vol. 4 (T. Hökfelt and A. Bjorklund, eds.), pp. 355–405, Elsevier, Amsterdam.Google Scholar
  47. Emson, P. C., Horsfield, P. M., Goedert, M., Rossor, M. N., and Hawkes, C. H., 1985b, Neurotensin in human brain: Regional distribution and effects of neurological illness, Brain Res. 347:239–244.PubMedCrossRefGoogle Scholar
  48. Ervin, G. N., Birkemo, L. S., Nemeroff, C. B., and Prange, A. J., Jr., 1981, Neurotensin blocks certain amphetamine behaviors, Nature 291:73–76.PubMedCrossRefGoogle Scholar
  49. Fernstrom, M. H., Carraway, R. E., and Leeman, S. E., 1980, Neurotensin, in: Frontiers in Neu-roendocrinology, Vol. 6 (L. Martini and W. F. Ganong, eds.), pp. 103–127, Raven Press, New York.Google Scholar
  50. Finn, P. W., Robson, B., and Griffiths, E. C., 1984, Conformational study of neurotensin, Int. J. Peptide Protein Res. 24:407–413.CrossRefGoogle Scholar
  51. Fox, J. E. T., Sakai, Y., Jury, J., McLean, J., and Daniel, E. E., 1982, Neurotensin, evidence for multiple receptors for gastrointestinal motility action in dogs, Ann. N.Y. Acad. Sci. 400:398–399.CrossRefGoogle Scholar
  52. Frye, G. D., Luttinger, D., Nemeroff, C. B., Vogel, R. A., Prange, A. J., Jr., and Breese, G. R., 1981, Modification of the actions of ethanol by centrally active peptides, Peptides 2(Suppl. l):99–106.PubMedCrossRefGoogle Scholar
  53. Furuta, S., Kisara, K., Sakurada, S., Sakurada, T., Sasaki, V., and Suzuki, K., 1984, Struc-ture-antinociceptive activity studies with neurotensin, Br. J. Pharmacol. 83:43–48.PubMedGoogle Scholar
  54. Fuxe, K., Agnati, L. F., Benfenati, F., Celani, M., Zini, I., Zoli, M., and Mutt, V., 1983, Evidence for the existence of receptor-receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides, J. Neural Transm. (Suppl.) 19:165–179.Google Scholar
  55. Garcia-Sevilla, J. A., Magnusson, T., Carlsson, A., Leban, J., and Folkers, K., 1978, Neurotensin and its amide analogue [Gln4]-neurotensin: Effects on brain monoamine turnover, Naunyn Schmiedebergs Arch. Pharmacol. 305:213–218.PubMedCrossRefGoogle Scholar
  56. Gerlach, J., Thorse, K., and Fog, R., 1975, Extrapyramidal reactions and amine metabolites in cere-brospinal fluid during haloperidol and clozapine treatment of schizophrenic patients, Psychophar-macologia 40:341–350.CrossRefGoogle Scholar
  57. Ghatei, M. A., Bloom, S. R., Langerin, H., McGregor, G. P., Lee, Y. C., Adrian, T. E., O’Shaughessy, D. J., Blank, M. A., and Uttenthal, L. O., 1984, Regional distribution of bombesin and seven other regulatory peptides in the human brain, Brain Res. 293:101–109.PubMedCrossRefGoogle Scholar
  58. Gilbert, J. A., and Richelson, E., 1984, Neurotensin stimulates formation of cyclic GMP in murine neuroblastoma clone N1E-115, Eur. J. Pharmacol. 99:245–246.PubMedCrossRefGoogle Scholar
  59. Gilbert, J. A., McKinney, M., and Richelson, E., 1984, Neurotensin stimulates cyclic GMP formation in neuroblastoma clone N1E-115 and rat cerebellum, Soc. Neurosci. Abstr. 10:378.Google Scholar
  60. Glimcher, P., Margolin, D., and Hoebel, B. G., 1982, Rewarding effects of neurotensin in the brain, Ann. N.Y. Acad. Sci. 400:422–424.CrossRefGoogle Scholar
  61. Glimcher, P. W., Margolin, D. H., Giovino, A. A., and Hoebel, B. G., 1984, Neurotensin: A new “reward peptide,” Brain Res. 291:119–124.PubMedCrossRefGoogle Scholar
  62. Gmerek, D. E., and Cowan, A., 1981, Tolerance and cross-tolerance studies on the grooming and shaking effects of ACTH-(l-24), bombesin and RX 336-M, Fed. Proc. 223:274.Google Scholar
  63. Goedert, M., 1984, Neurotensin—a status report, Trends Neurosci. 7:3–5.CrossRefGoogle Scholar
  64. Goedert, M., Mantyh, P. W., Hunt, S. P., and Emson, P. C., 1983, Mosaic distribution of neurotensin-like immunoreactivity in the cat striatum, Brain Res. 274:176–179.PubMedCrossRefGoogle Scholar
  65. Goedert, M., Mantyh, P. W., Emson, P. C., and Hunt, S. P., 1984a, Inverse relationship between neurotensin receptors and neurotensin-like immunoreactivity in cat striatum, Nature 307:543–546.PubMedCrossRefGoogle Scholar
  66. Goedert, M., Pittaway, K., and Emson, P. C., 1984b, Neurotensin receptors in the rat striatum: Lesion studies, Brain Res. 299:164–168.PubMedCrossRefGoogle Scholar
  67. Goedert, M., Pittaway, K., Williams, B. J., and Emson, P. C., 1984c, Specific binding of tritiated neurotensin to rat brain membranes: Characterization and regional distribution, Brain Res. 304:71–81.PubMedCrossRefGoogle Scholar
  68. Goedert, M., Sturmey, N., Williams, B., and Emson, P. C., 1984d, The comparative distribution of xenopsin-and neurotensin-like immunoreactivity in Xenopus laevis and rat tissues, Brain Res. 308:273–280.PubMedCrossRefGoogle Scholar
  69. Goedert, M., Iversen, S. D., and Emson, P. C., 1985, The effects of chronic neuroleptic treatment on neurotensin-like immunoreactivity in the rat central nervous system, Brain Res. 335:334–336.PubMedCrossRefGoogle Scholar
  70. Govoni, S., Hong, J. S., Yang, H.-Y. T., and Costa, E., 1980, Increase of neurotensin content elicited by neuroleptics in nucleus accumbens, J. Pharmacol. Exp. Ther. 215:413–417.PubMedGoogle Scholar
  71. Grant, L. D., Nemeroff, C. B., and Bissette, G., 1982, Neuroanatomical distribution of neuroactive peptides in mammalian species, in: Peptides, Hormones and Behavior (C. B. Nemeroff and A. J. Dunn, eds.), pp. 37–98, Spectrum Press, New York.Google Scholar
  72. Griffiths, E. C., Widdowson, P., and Slater, P., 1982, Antagonism of TRH-induced wet-dog shaking in rats by neurotensin and a neurotensin fragment, Neurosci. Lett. 31:17.CrossRefGoogle Scholar
  73. Griffiths, E. C., McDermott, J. R., and Smith, A. I., 1984, A comparative study of neurotensin inactivation by brain peptidases from different vertebrate species, Comp. Biochem. Physiol. 77C:363–366.Google Scholar
  74. Grimmelikhuijzen, C. J. P., Carraway, R. E., Rokaeus, A., and Sundler, F., 1981, Neurotensin-like immunoreactivity in the nervous system of hydra, Histochemistry 72:199–209.PubMedCrossRefGoogle Scholar
  75. Guyenet, P. G., and Aghajanian, G. K., 1977, Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides, Brain Res. 136:178–184.PubMedCrossRefGoogle Scholar
  76. Haubrich, D. R., Martin, G. E., Pflueger, B., and Williams, M., 1982, Neurotensin effects on brain dopaminergic systems, Brain Res. 231:216–221.PubMedCrossRefGoogle Scholar
  77. Henry, J. L., 1982, Electrophysiological studies on the neuroactive properties of neurotensin, Ann. N.Y. Acad. Sci. 400:216–227.PubMedCrossRefGoogle Scholar
  78. Hernandez, D.E., Nemeroff, C.B., and Prange, A. J., Jr., 1982, Ontogeny of the hypothermic response to centrally administered neurotensin in rats, Dev. Brain Res. 3:497–501.CrossRefGoogle Scholar
  79. Hernandez, D., Nemeroff, C. B., Valderrama, M. M., and Prange, A. J., Jr., 1984a, Neurotensin-induced antinociception and hypothermia in mice: Antagonism by TRH and structural analogs of TRH, Regul. Peptides 8:41–49.CrossRefGoogle Scholar
  80. Hernandez, D. E., Richardson, C. M., Nemeroff, C. B., Orlando, R. C., St.-Pierre, S., Rioux, F., and Prange, A. J., 1984b, Evidence for biological activity of two N-terminal fragments of neurotensin, neurotensin1–8 and neurotensin1–10, Brain Res. 301:153–156.PubMedCrossRefGoogle Scholar
  81. Hoebel, B. G., 1984, Neurotransmitters in the control of feeding and its rewards: Monoamines, opiates and brain-gut peptides, in: Eating and Its Disorders (A. J. Stunkard and E. Stellar, eds.), pp. 15–38, Raven Press, New York.Google Scholar
  82. Hoebel, B. G., Hernandez, L., McLean, S., Stanley, B. G., Aulissi, E. F., Elimacher, P., and Margolin, D., 1982, Catecholamines, enkephalin, and neurotensin in feeding and reward, in: The Neural Basis of Feeding and Reward (B. G. Hoebel and D. Novin, eds.), pp. 465–478, Haer Institute, Sebasco, ME.Google Scholar
  83. Hokfelt, T., Everitt, B. J., Theodorsson-Norheim, E., and Goldstein, M., 1984, Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons, J. Comp. Neurol. 222:543–559.PubMedCrossRefGoogle Scholar
  84. Hylden, J. L. K., and Wilcox, G. L., 1983, Antinociceptive action of intrathecal neurotensin in mice, Peptides 4:517–520.PubMedCrossRefGoogle Scholar
  85. Ibata, Y., Okamura, F. H., Kawakami, T., Tanaka, M., Obata, H. L., Tsuto, O. T., Terubayashi, H., Yanaihara, C., and Yanaihara, N., 1983, Coexistence of dopamine and neurotensin in hypothalamic arcuate and periventricular neurons, Brain Res. 269:177–179.PubMedCrossRefGoogle Scholar
  86. Ibata, Y., Kawakami, F., Fukui, K., Obata-Tsuto, H. L., Tanaka, M., Kubo, T., Okamura, H., Morimoto, N., Yanaihara, C., and Yanaihara, N., 1984a, Light and electron microscopic im-munocytochemistry of neurotensin-like immunoreactive neurons in the rat hypothalamus, Brain Res. 302:221–230.PubMedCrossRefGoogle Scholar
  87. Ibata, Y., Kawakami, G., Fukui, K., Okamura, H., Obata-Tsuto, H. L., Tsuto, T., and Terubayashi, H., 1984b, Morphological survey of neurotensin-like immunoreactive neurons in the hypothalamus, Peptides 5:109–120.PubMedCrossRefGoogle Scholar
  88. Inagaki, S., Yamano, M., Shiosaka, S., Takagi, H., and Tohyama, M., 1983a, Distribution and origins of neurotensin-containing fibers in the nucleus ventromedialis hypothalamai of the rat: An experimental immunohistochemical study, Brain Res. 273:229–235.PubMedCrossRefGoogle Scholar
  89. Inagaki, S., Shinoda, K., Kubota, Y., Shiosaka, S., Marsuzaki, T., and Tohyama, M., 1983b, Evidence for the existence of a neurotensin-containing pathway from the endopiriform nucleus and the adjacent prepiriform cortex to the anterior olfactory nucleus and nucleus of diagonal band (Broca) of the rat, Neuroscience 8:487–493.PubMedCrossRefGoogle Scholar
  90. Iversen, L. L., Iversen, S. D., Bloom, F., Douglas, C., Brown, M., and Vale, W., 1978, Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro, Nature 273:161.PubMedCrossRefGoogle Scholar
  91. Jennes, L., Stumpf, W. E., and Kalivas, P. W., 1982, Neurotensin: Topographical distribution in rat brain by immunohistochemistry, J. Comp. Neurol. 210:211–224.PubMedCrossRefGoogle Scholar
  92. Jolicoeur, F. B., and Barbeau, A., 1982, Pharmacological evidence for a heterogeneity of receptors underlying various central and peripheral effects of neurotensin, Ann. N.Y. Acad. Sci. 400:440–441.CrossRefGoogle Scholar
  93. Jolicoeur, F. B., Barbeau, A., Rioux, F., Quirion, R., and St. Pierre, S., 1981a, Differential neuro-behavioral effects of neurotensin and structural analogues, Peptides 2:171–175.PubMedCrossRefGoogle Scholar
  94. Jolicoeur, F. B., Rondeau, D., St. Pierre, S., Rioux, F., and Barbeau, A., 1981b, Peptides and the basal ganglia, in: Clinical Pharmacology of Apomorphine and Other Dopamimetrics (J. L. Gessa and G. U. Corsini, eds.), pp. 19–25, Raven Press, New York.Google Scholar
  95. Jolicoeur, F. B., Barbeau, A., Quirion, R., Rioux, F., and St. Pierre, S., 1982a, Pharmacological evidence for a heterogeneity of receptors in developing various central and peripheral effects of neurotensin, Ann. N.Y. Acad. Sci. 400:440–441.CrossRefGoogle Scholar
  96. Jolicoeur, F. B., Rioux, F., St.-Pierre, S., and Barbeau, A., 1982b, Structure-activity studies of neurotensin’s neurobehavioral effects, in: Brain Neurotransmitters and Hormones (R. Collu, A. Barbeau, J. R. Ducharme, and G. Tollis, eds.), Raven Press, New York, pp. 171–183.Google Scholar
  97. Jolicoeur, F. B., De Michele, G., and Barbeau, A., 1983, Neurotensin affects hyperactivity but not stereotypy induced by pre-and post-synaptic dopaminergic stimulation, Neurosci. Biobehav. Rev. 7:385–390.PubMedCrossRefGoogle Scholar
  98. Jolicoeur, F. B., St. Pierre, S., Aube, C., Riuest, R., and Grogne, M. A., 1984, Relationships between structure and duration of neurotensin’s central action: Emergence of long-lasting analogs, Neuro-peptides 4:467–476.Google Scholar
  99. Jolicoeur, F. B., Rioux, F., and St. Pierre, S., 1985, Neurotensin, in: Handbook of Neurochemistry, Vol. 8 (A. Lajtha, ed.), pp. 94–114, Plenum Press, New York.Google Scholar
  100. Kahn, D., Abrams, G. M., Zimmerman, E. A., Carraway, R., and Leeman, S. E., 1980, Neurotensin neurons in the rat hypothalamus: An immunocytochemical study, Endocrinology 107:47–54.PubMedCrossRefGoogle Scholar
  101. Kalivas, P. W., 1984, Neurotensin in the ventromedial mesencephalon of the rat: Anatomical and functional considerations, J. Comp. Neurol. 226:495–507.PubMedCrossRefGoogle Scholar
  102. Kalivas, P. W., and Miller, J. S., 1984, Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens, Brain Res. 300:157–160.PubMedCrossRefGoogle Scholar
  103. Kalivas, P. W., Nemeroff, C. B., and Prange, A. J., Jr., 1981, Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area, Brain Res. 229:525–529.PubMedCrossRefGoogle Scholar
  104. Kalivas, P. W., Nemeroff, C. B., and Prange, A. J., Jr., 1982b, Neuroanatomical sites of action of neurotensin, Ann. N.Y. Acad. Sci. 400:307–318.PubMedCrossRefGoogle Scholar
  105. Kalivas, P. W., Gau, B., Nemeroff, C. B., and Prange, A. J., Jr., 1982c, Antinociception after microinjection of neurotensin into the central amygdaloid nucleus of the rat, Brain Res. 243:279–286.PubMedCrossRefGoogle Scholar
  106. Kalivas, P. W., Jennes, L., Nemeroff, C. B., and Prange, A. J., Jr., 1982d, Neurotensin: Topographic distribution of brain sites involved in hypothermia and antinociception, J. Comp. Neurol. 210:225–238.PubMedCrossRefGoogle Scholar
  107. Kalivas, P. W., Hernandez, D. E., Bissette, G., Mason, G. A., Nemeroff, C. B., and Prange, A. J., Jr., 1983a, Neurotensin-induced hypothermia: Neuroanatomical and neurochemical mechanisms, in: Proceedings Pharmacology Thermoregulation 5th International Meeting (P. Lomax and E. Schonbaum, eds.), pp. 108–112, S. Karger, Basel.Google Scholar
  108. Kalivas, P. W., Burgess, S. K., Nemeroff, C. B., and Prange, A. J., Jr., 1983b, Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat, Neuroscience 8:495–505.PubMedCrossRefGoogle Scholar
  109. Kalivas, P. W., Nemeroff, C. B., and Prange, A. J., Jr., 1984, Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing, Neuroscience 11:919–930.PubMedCrossRefGoogle Scholar
  110. Kataoka, K., Mizumo, N., and Frohman, L. A., 1979, Regional distribution of immunoreactive neurotensin in monkey brain, Brain Res. Bull. 4:57–60.PubMedCrossRefGoogle Scholar
  111. Kilts, C. D., Bissette, G., Cain, S. T., Skoog, K. M., and Nemeroff, C. B., 1986, Neuropeptide-dopamine interactions: Focus on neurotensin, in: Dopamine’ 84 (G. N. Woodruff and P. J. Roberts, eds.), Macmillan, London (in press).Google Scholar
  112. Kitabgi, P., Carraway, R., and Leeman, S. E., 1976, Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin, J. Biol. Chem. 251:7053–7058.PubMedGoogle Scholar
  113. Kitabgi, P., Carraway, R., Van Rietschoten, J., Granier, C., Morgat, J. L., Mendez, A., Leeman, S., and Freychet, P., 1977, Neurotensin: Specific binding to synaptic membranes from rat brain, Proc. Nail. Acad. Sci. U.S.A. 74:1846–1850.CrossRefGoogle Scholar
  114. Kitabgi, P., Poustis, C., Granier, C., Van Rietschoten, J., Rivier, J., Morgat, J. L., and Freychet, P., 1980, Neurotensin binding to extraneural and neural receptors: Comparison with biological activity and structure-activity relationships, Mol. Pharmacol. 18:11–19.PubMedGoogle Scholar
  115. Kleinman, J. E., Iadarola, M., Govoni, S., Hong, J., Gillin, J. C., and Wyatt, R. J., 1983, Postmortem measurements of neuropeptides in human brain, Psychopharmacol Bull. 19:375–377.Google Scholar
  116. Kobayashi, R. M., Brown, M. R., and Vale, W., 1977, Regional distribution of neurotensin and somatostatin in rat brain, Brain Res. 126:584–588.PubMedCrossRefGoogle Scholar
  117. Köhler, C., and Eriksson, L. G., 1984, An immunohistochemical study of somatostatin and neurotensin positive neurons in the septal nuclei of the rat brain, Anat. Embryol. 170:1–10.PubMedCrossRefGoogle Scholar
  118. Langer, M., Van Noorden, S., Polak, J. M., and Pearse, A. G. E., 1979, Peptide hormone-like immunoreactivity in the gastrointestinal tract and endocrine pancreas of eleven teleost species, Cell Tissue Res. 199:493–508.PubMedCrossRefGoogle Scholar
  119. Lazarus, L. H., Brown, M. R., and Perrin, H. H., 1977a, Distribution, localization, and characterization of neurotensin binding sites in the rat brain, Neuropharmacology 16:625–629.PubMedCrossRefGoogle Scholar
  120. Lazarus, L. H., Perrin, M. H., Brown, M. R., and Rivier, J. E., 1977b, Mast cell binding of neurotensin. II. Molecular conformation of neurotensin involved in the stereospecific binding of mast cell receptor sites, J. Biol. Chem. 252:7180–7183.PubMedGoogle Scholar
  121. Lazarus, L. H., Brown, M., Perrin, M. H., and Rivier, J. E., 1977d, Neurotensin: Mast cell receptor binding with comparison to biological activity, Fed. Proc. 36:1015.Google Scholar
  122. Lee, Y. C., Terenghi, G., Polak, J. M., and Bloom, S. R., 1981, Neurotensin in adrenal medulla of the rat, Acta Endocrinol. (Kbh.) 97(Suppl. 243):84.Google Scholar
  123. Lee, T. F., Hepler, J. R., and Myers, R. D., 1983, Evaluation of neurotensin’s thermolytic action by ICV infusion with receptor antagonists and a Ca++ chelator, Pharmacol. Biochem. Behav. 19: 477–481.PubMedCrossRefGoogle Scholar
  124. Leibowitz, S. F., 1978, Paraventricular nucleus: A primary site mediating adrenergic stimulation of feeding and drinking, Pharmacol. Biochem. Behav. 8:163–175.PubMedCrossRefGoogle Scholar
  125. Leranth, C. S., Jew, J. Y., Williams, T. H., and Palkovits, M., 1981, Stria terminalis axons ending on substance P and neurotensin-containing cells of rat central amygdaloid nucleus: An electron microscopic immunocytochemical study, Neuropeptides 1:261–272.CrossRefGoogle Scholar
  126. Levine, A. S., Kneip, J., Grace, M., and Morley, J. E., 1983, Effect of centrally administered neurotensin on multiple feeding paradigms, Pharmacol. Biochem. Behav. 18:19–23.PubMedCrossRefGoogle Scholar
  127. Lipton, M. A., Bissette, G., Nemeroff, C. B., Loosen, P. T., and Prange, A. J., Jr., 1977, Neurotensin: A possible mediator of thermoregulation in the mouse, in: Drugs, Biogenic Amines, and Body TemperatureThird Symposium on the Pharmacology of Thermoregulation (P. Lomax, E. Schom-baum, and B. Cox, eds.), pp. 54–57, S. Karger, Basel.Google Scholar
  128. Long, J. B., Kalivas, P. W., Youngblood, W. W., Prange, A. J., Jr., and Kizer, J. S., 1981, Selective effects of centrally administered neurotensin on in vivo tryptophan hydroxylase activity (THA) and serotonin (5HT) levels in discrete rat brain areas, Pharmacologist 23:133.Google Scholar
  129. Long, J. B., Kalivas, P. W., Youngblood, W. W., Prange, A. J., and Kizer, S., 1984, Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesia, Brain Res. 310:35–42.PubMedCrossRefGoogle Scholar
  130. Loosen, P. T., Nemeroff, C. B., Bissette, G., Burnett, G., Prange, A. J., Jr., and Lipton, M. A., 1978, Neurotensin-induced hypothermia in the rat: Structure-activity studies, Neuropharmacology 17:108–113.CrossRefGoogle Scholar
  131. Luttinger, D., Nemeroff, C. B., Mason, G. A., Frye, G. D., Breese, G. R., and Prange, A. J., Jr., 1981a, Enhancement of ethanol-induced sedation and hypothermia by centrally administered neurotensin, β-endorphin, and bombesin, Neuropharmacology 20:305–309.PubMedCrossRefGoogle Scholar
  132. Luttinger, D., Nemeroff, C. B., King, R. A., Ervin, G. N., and Prange, A. J., Jr., 1981b, The effect of injection of neurotensin into the nucleus accumbens on behaviors mediated by the mesolimbic dopamine system in the rat, in: The Neurobiology of the Nucleus Accumbens (R. B. Chronister and J. F. DeFrance, eds.), pp-322–332, Haer Institute for Electrophysiological Research, Sebasco, ME.Google Scholar
  133. Luttinger, D., Nemeroff, C. B., and Prange, A. J., Jr., 1981c, Inhibition of neurotensin-induced antinociception in morphine-tolerant mice, Pharmacologist 23:120.Google Scholar
  134. Luttinger, D., King, R. A., Sheppard, D., Strupp, J., Nemeroff, C. B., and Prange, A. J., Jr., 1982a, The effect of neurotensin on food consumption in the rat, Eur. J. Pharmacol. 81:499–504.PubMedCrossRefGoogle Scholar
  135. Luttinger, D., Nemeroff, C. B., and Prange, A. J., Jr., 1982b, The effects of neuropeptides on discrete-trial conditioned avoidance responding, Brain Res. 237:183–192.PubMedCrossRefGoogle Scholar
  136. Luttinger, D. E., Burgess, S. K., Nemeroff, C. B., and Prange, A. J., Jr., 1983a, The effect of chronic morphine treatment on neurotensin-induced antinociception, Psychopharmacology 81:10–13.PubMedCrossRefGoogle Scholar
  137. Luttinger, D., Frye, G. D., Nemeroff, C. B., and Prange, A. J., Jr., 1983b, The effects of neurotensin, β-endorphin and bombesin on ethanol-induced behaviors in mice, Psychopharmacology 79:357–363.PubMedCrossRefGoogle Scholar
  138. Maeda, K., and Frohman, L. A., 1978, Dissociation of systemic and central effects of neurotensin on the secretion of growth hormone, prolactin, and thyrotropin, Endocrinology 103:1903–1909.PubMedCrossRefGoogle Scholar
  139. Maeda, K., and Frohman, L. A., 1981, Neurotensin release by rat hypothalamic fragments in vitro, Brain Res. 210:261–269.PubMedCrossRefGoogle Scholar
  140. Manberg, P. J., Youngblood, W. W., Nemeroff, C. B., Rossor, M., Iversen, L. L., Prange, A. J., Jr., and Kizer, J. S., 1982a, Regional distribution of neurotensin in human brain, J. Neurochem. 38:1777–1780.PubMedCrossRefGoogle Scholar
  141. Manberg, P. J., Nemeroff, C. B., Iversen, L. L., Rosser, M. N., Kizer, J. S., and Prange, A. J., Jr., 1982b, Human brain distribution of neurotensin in normals, schizophrenics and Huntington’s chor-eics, Ann. N.Y. Acad. Sci. 400:354–367.PubMedCrossRefGoogle Scholar
  142. Martin, G. E., and Naruse, S. T., 1982, Differences in the pharmacological actions of intrathecally administered neurotensin and morphine, Regul. Peptides 3:97–103.CrossRefGoogle Scholar
  143. Martin, G. E., Naruse, T., and Papp, N. L., 1981a, Antinociceptive and hypothermic actions of neurotensin administered centrally in the rat, Neuropeptides 1:447–454.CrossRefGoogle Scholar
  144. Martin, G. E., Bacino, C. B., and Papp, N. L., 1981b, Hypothermia elicited by intracerebral microinjection of neurotensin, Peptides 1:333–339.CrossRefGoogle Scholar
  145. Martins, A. R., Caldo, H., Coelho, H. L., Moreira, A. C., Antines-Rodriguez, J., Greene, L. J., and de Camarco, A. C. M., 1980, Screening for rabbit brain neuropeptide-metabolizing peptidases. Inhibition of endopeptidase B by bradykinin-potentiating peptide 9a (SQ 20881), J. Neurochem. 34:100–107.PubMedCrossRefGoogle Scholar
  146. Marwaha, J., Hoffer, B., and Breedman, R., 1980, Electrophysiological actions of neurotensin in rat cerebellum, Regul. Peptides 1:115–125.CrossRefGoogle Scholar
  147. Mashford, M. L., Nilsson, G., Rokaeus, A., and Rosell, S., 1978, The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in the human, Acta Physiol. Scand. 104: 244–246.PubMedCrossRefGoogle Scholar
  148. Mason, G. A., Nemeroff, C. B., Luttinger, D., Hatley, O. L., and Prange, A. J., Jr., 1980, Neurotensin and bombesin: Differential effects on body temperature of mice after intracisternal administration, Regul. Peptides 1:53–60.CrossRefGoogle Scholar
  149. Mazella, J., Poustis, C., Labbe, C., Checler, F., Kitabgi, P., Granier, C., van Rietschoten, J., and Vincent, J. P., 1983, Monoiodo-[Trp11]-neurotensin, a highly radioactive ligand of neurotensin receptors, J. Biol. Chem. 258:3476–3481.PubMedGoogle Scholar
  150. McCarthy, P. S., Walker, R. J., Yajima, H., Kitagawa, K., and Woodruff, G. N., 1979, The action of neurotensin on neurones in the nucleus accumbens and cerebellum of the rat, Gen. Pharmacol. 10:331–333.PubMedCrossRefGoogle Scholar
  151. McDermott, J. R., and Kidd, A. N., 1984, Ion-exchange gel-filtration and reversed-phase high-performance liquid chromatography in the isolation of neurotensin-degrading enzymes from rat brain, J. Chromatogr. 290:231–239.CrossRefGoogle Scholar
  152. McDermott, J. R., Smith, A. I., Edwardson, J. A., and Griffiths, E. C., 1982, Mechanism of neurotensin degradation by rat brain peptidases, Regul. Peptides 3:397–404.CrossRefGoogle Scholar
  153. Merritt, W. D., Bissett, G., Luttinger, D., Prange, A. J., Jr., and Nemeroff, C. B., 1986, Adaptation to cold antagonizes neurotensin-induced hypothermia in mice, Brain Res. 369:136–142.PubMedCrossRefGoogle Scholar
  154. Metcalf, G., Dettmar, P., and Watson, T., 1980, The role of neuropeptides in thermoregulation, in: Thermoregulatory Mechanisms and Their Therapeutic Implications (B. Cox, P. Lomax, A. S. Milton, and E. Schonbaum, eds.), pp. 175–179, S. Karger, Basel.Google Scholar
  155. Miletic, V., and Randic, M., 1979, Neurotensin excites cat spinal neurones in laminae 1-111, Brain Res. 169:600–604.PubMedCrossRefGoogle Scholar
  156. Milner, T. A., Joh, T. H., Miller, R. J., and Pickel, V. M., 1984, Substance P, neurotensin, enkephalin, and catecholamine-synthesizing enzymes: Light microscopic localizations compared with autora-diographic label in solitary efferents to the rat parabrachial region, J. Comp. Neurol. 220:434–447.CrossRefGoogle Scholar
  157. Minamino, N., Kargawa, K., and Matsuo, H., 1984, Neuromedin N: A novel neurotensin-like peptide identified in porcine spinal cord, Biochem. Biophys. Res. Commun. 122:542–549.PubMedCrossRefGoogle Scholar
  158. Moore, R. Y., and Bloom, F. E., 1978, Central catecholamine neurone systems: Anatomy and physiology of the dopamine system, Annu. Rev. Neurosci. 1:129–169.PubMedCrossRefGoogle Scholar
  159. Mora, F., Lee, T. F., and Myers, R. D., 1984, Is neurotensin in the brain involved in thermoregulation of the monkey? Peptides 5:125–128.PubMedCrossRefGoogle Scholar
  160. Morley, J. E., and Levine, A. S., 1981, Bombesin inhibits stress-induced eating, Pharmacol. Biochem. Behav. 14:149–151.PubMedCrossRefGoogle Scholar
  161. Morley, J. E., Levine, A. S., Oken, M. M., Grace, M., and Kneip, J., 1982, Neuropeptides and thermoregulation: The interactions of bombesin, neurotensin, TRH, somatostatin, naloxone and prostaglandins, Peptides 3:1–6.PubMedCrossRefGoogle Scholar
  162. Myers, R. D., and Lee, T. F., 1984a, Neurotensin perfusion of rat hypothalamus: Dissociation of dopamine release from body temperature change, Neuroscience 12:241–253.PubMedCrossRefGoogle Scholar
  163. Myers, R. D., and Lee, T. F., 1984b, In vivo release of dopamine during perfusion of neurotensin in the substantia nigra of the unrestrained rat, Peptides 4:955–961.CrossRefGoogle Scholar
  164. Nagai, K., and Frohman, L. A., 1976, Hyperglycemia and hyperglucagonemia following neurotensin administration, Life Sci. 19:273–280.PubMedCrossRefGoogle Scholar
  165. Nakagawa, Y., Higashida, H., and Miki, N., 1984, A single class of neurotensin receptors with high affinity in neuroblastoma and glioma NG108-15 hybrid cells that mediate facilitation of synaptic transmission, J. Neurosci. 4:1053–1601.Google Scholar
  166. Nemeroff, C. B., 1980, Neurotensin: Perchance an endogenous neuroleptic? Biol. Psychiatry 15:283–302.PubMedGoogle Scholar
  167. Nemeroff, C. B., 1986, The interaction of neurotensin with dopaminergic pathways in the central nervous system: Basic neurobiology and implications for the pathogenesis and treatment of schizophrenia, P sychoneuroendocrinology 11:15–37.Google Scholar
  168. Nemeroff, C. B., and Cain, S. T., 1985, Neurotensin-dopamine interactions in the central nervous stem, Trends Pharmacol. Sci 6:201–205.CrossRefGoogle Scholar
  169. Nemeroff, C. B., Bissette, G., Prange, A. J., Jr., Loosen, P. T., Barlow, T. S., and Lipton, M. A., 1977, Neurotensin: Central nervous system effects of a hypothalamic peptide, Brain Res. 128:485–496.PubMedCrossRefGoogle Scholar
  170. Nemeroff, C. B., Osbahr, A. J. III, Manberg, P. J., Ervin, G. N., and Prange, A. J., Jr., 1979, Alterations in nociception and body temperature after intracisternally administered neurotensin, β-endorphin, other endogenous peptides, and morphine, Proc. Natl. Acad. Sci. U.S.A. 76:5368–5371.PubMedCrossRefGoogle Scholar
  171. Nemeroff, C. B., Bissette, G., Manberg, P. J., Moore, S. I., Ervin, G. N., Osbahr, A. J. III, and Prange, A. J., Jr., 1980a, Hypothermie responses to neurotensin in vertebrates, in: Thermoregulatory Mechanisms and Their Therapeutic Implications (B. Cox, P. Lomax, A. S. Milton, and E. Schonbaum, eds.), pp. 180–185, S. Karger, Basel.Google Scholar
  172. Nemeroff, C. B., Bissette, G., Manberg, P. J., Osbahr, A. J. III, Breese, G. R., and Prange, A. J., Jr., 1980b, Neurotensin-induced hypothermia: Evidence for an interaction with dopaminergic systems and the hypothalamic-pituitary-thyroid axis, Brain Res. 195:69–84.PubMedCrossRefGoogle Scholar
  173. Nemeroff, C. B., Hernandez, D. E., Luttinger, D., Kalivas, P., and Prange, A. J., Jr., 1982, Interactions of neurotensin with brain dopamine systems, Ann. N.Y. Acad. Sci. 400:330–344.PubMedCrossRefGoogle Scholar
  174. Nemeroff, C. B., Luttinger, D., Hernandez, D. E., Mailman, R. B., Mason, G. A., Davis, S. D., Widerlov, E., Frye, G. D., Kilts, C. D., Beaumont, K., Breese, G. R., and Prange, A. J., Jr., 1983a, Interactions of neurotensin with brain dopamine systems: Biochemical and behavioral studies, J. Pharmacol. Exp. Ther. 225:337–345.PubMedGoogle Scholar
  175. Nemeroff, C. B., Youngblood, W., Manberg, P. J., Prange, A. J., Jr., and Kizer, J. S., 1983b, Regional brain concentrations of neuropeptides in Huntington’s chorea and schizophrenia, Science 221:972–975.PubMedCrossRefGoogle Scholar
  176. Nemeroff, C. B., Bissette, G., Busby, W. H., Youngblood, W. W., Rossor, M., Roth, M., and Kizer, J. S., 1983c, Regional concentrations of neurotensin, thyrotropin-releasing hormone, and somato-statin in Alzheimer’s disease, Soc. Neurosci. Abstr. 9:1052.Google Scholar
  177. Nemeroff, C. B., Kalivas, P. W., and Prange, A. J., Jr., 1984, Interaction of neurotensin and dopamine in limbic structures, in: Catecholamines: Neuropharmacology and Central Nervous SystemTheoretical Aspects (E. Usdin, A. Carlsson, A. Dahlstrom, and J. Engel, eds.), pp. 199–205, Alan R. Liss, New York.Google Scholar
  178. Nicoll, R. A., 1978, The action of thyrotropin-releasing hormone, substance P, and related peptides on frog spinal motoneurons, J. Pharmacol. Exp. Ther. 207:817–824.PubMedGoogle Scholar
  179. Ninkovic, M., Hunt, S. P., and Kelly, J. S., 1981, Effect of dorsal rhizotomy on the autoradiographic distribution of opiate and neurotensin receptors and neurotensin-like immunoreactivity within the rat spinal cord, Brain Res. 230:111–119.PubMedCrossRefGoogle Scholar
  180. Okuma, Y., and Osumi, Y., 1982, Neurotensin-induced release of endogenous noradrenaline from rat hypothalamic slices, Life Sci. 30:77–84.PubMedCrossRefGoogle Scholar
  181. Okuma, Y., Fukuda, Y., and Osumi, Y., 1983, Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices, Eur. J. Pharmacol. 93:27–33.PubMedCrossRefGoogle Scholar
  182. Ondetti, M. A., Rubin, B., and Cushman, D. W., 1977, Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents, Science 196:441–444.PubMedCrossRefGoogle Scholar
  183. Osbahr, A. J. III, Nemeroff, C. B., Manberg, P. H., and Prange, A. J., Jr., 1979, Centrally administered neurotensin: Activity in the Julou-Courvosier muscle relaxation test in mice, Eur. J. Pharmacol. 54:299–302.PubMedCrossRefGoogle Scholar
  184. Osbahr, A. J. III, Nemeroff, C. B., Luttinger, D., Mason, G. A., and Prange, A. J., Jr., 1981, Neurotensin-induced analgesia in mice: Antagonism by thyrotropin-releasing hormone, J. Pharmacol. Exp. Ther. 217:645–651.PubMedGoogle Scholar
  185. Palacios, J. M., and Kuhar, M. J., 1981, Neurotensin receptors are located on dopamine-containing neurons in rat midbrain, Nature 294:587–589.PubMedCrossRefGoogle Scholar
  186. Phillis, J. W., and Kirkpatrick, J. R., 1979, Action of various gastrointestinal peptides on the isolated amphibian spinal cord, Can. J. Physiol. Pharmacol. 57:887–889.PubMedCrossRefGoogle Scholar
  187. Phillis, J. W., and Kirkpatrick, J. R., 1980, The actions of motilin, leuteinizing-hormone-releasing hormone, cholecystokinin, somatostatin, vasoactive intestinal peptide, and other peptides on rat cerebral neurons, Can. J. Physiol. Pharmacol. 58:612–623.PubMedCrossRefGoogle Scholar
  188. Poustis, C., Mazella, J., Kitabgi, P., and Vincent, S. P., 1984, High affinity neurotensin binding sites in differentiated neuroblastoma NIE 115 cells, J. Neurochem. 42:1094–1100.PubMedCrossRefGoogle Scholar
  189. Prange, A. J., Jr., Nemeroff, C. B., Bissette, G., Manberg, P. J., Osbahr, A. J. III, Burnett, G. B., Loosen, P. T., and Kraemer, G. W., 1979, Neurotensin: Distribution of hypothermic response in mammalian and submammalian vertebrates, Pharmacol. Behav. 11:473–477.CrossRefGoogle Scholar
  190. Price, C. H., Ruane, S. E., and Carraway, R. E., 1982, Biochemistry and physiology of neurotensin-like peptides in the brain and gut of the mollusc Aplysia, Ann. N.Y. Acad. Sci. 400:409–410.CrossRefGoogle Scholar
  191. Quirion, R., 1983, Interactions between neurotensin and dopamine in the brain: An overview, Peptides 4:609–615.PubMedCrossRefGoogle Scholar
  192. Quirion, R., Rioux, F., St. Pierre, S., Belanger, F., Jolicoeur, F. B., and Barbeau, A., 1981, Hy-potensive effects of centrally and peripherally administered neurotensin and neurotensin derivatives in rats, Neuropeptides 1:253–259.CrossRefGoogle Scholar
  193. Quirion, R., Gaudreau, P., St. Pierre, S., and Rioux, F., 1982a, Localization of neurotensin binding sites in rat kidney, Peptides 3:765–769.PubMedCrossRefGoogle Scholar
  194. Quirion, R., Gaudreau, P., St. Pierre, S., Rioux, F., and Pert, C., 1982b, Autoradiographic distribution of [3H]neurotensin receptors in rat brain, Peptides 3:757–763.PubMedCrossRefGoogle Scholar
  195. Quirion, R., Larsen, T. A., Caine, D., Chase, T., Rioux, F., St. Pierre, S., Evarist, H., Pert, A., and Pert, C. B., 1982c, Analysis of [3H]neurotensin receptors by computerized densitometry: Visualization of central and peripheral neurotensin receptors, Ann. N.Y. Acad. Sci. 400: 415–417.CrossRefGoogle Scholar
  196. Quirion, R., Everist, H. D., and Pert, A., 1982d, Nigrostriatal dopamine terminals bear neurotensin receptors but the mesolimbic do not, Soc. Neurosci. Abstr. 8:582.Google Scholar
  197. Reches, A., Burke, R. E., Jiang, D., Wagner, H. R., and Fahn, S., 1982, The effect of neurotensin on dopaminergic neurons in rat brain, Ann. N.Y. Acad. Sci. 400:420–421.CrossRefGoogle Scholar
  198. Reches, A., Burke, R. E., Jiant, D. H., Wagner, H. R., and Fahn, S., 1983, Neurotensin interactions with dopaminergic neurons in rat brain, Peptides 4:43–48.PubMedCrossRefGoogle Scholar
  199. Reinecke, M., Almasan, K., Carraway, R., Helmstaedter, V., and Forssman, W. G., 1980a, Distribution patterns of neurotensin-like immunoreactive cells in the gastrointestinal tract of vertebrates, Cell Tissue Res. 205:383–395.PubMedCrossRefGoogle Scholar
  200. Reinecke, M., Carraway, R. E., Falkemer, S., Feurley, G. E., and Forssman, W. G., 1980b, Occurrence of neurotensin-immunoreactive cells in the digestive tract of lower vertebrates and deuterostomian invertebrates, Cell Tissue Res. 212:173–183.PubMedCrossRefGoogle Scholar
  201. Reinecke, M., Forssmann, W. G., Thiekotter, G., and Triepel, J., 1983, Localization of neurotensin-immunoreactivity in the spinal cord and peripheral nervous system of the guinea pig, Neurosci. Lett. 37:37–12.PubMedCrossRefGoogle Scholar
  202. Rinkel, G. J. E., Hoeke, E. C., and van Wimersma-Greidanus, T.-J. B., 1983, Elective tolerance to behavioral effects of neurotensin, Pharmacol. Behav. 31:467–470.CrossRefGoogle Scholar
  203. Rioux, F., Quirion, R., Regoli, D., Leblanc, M.-A., and St. Pierre, S., 1980, Pharmacological characterization of neurotensin receptors in the rat isolated portal vein using analogues and fragments of neurotensin, Eur. J. Pharmacol. 66:273–279.PubMedCrossRefGoogle Scholar
  204. Rioux, F., Quirion, R., St. Pierre, S., Regoli, D., Jolicoeur, F., Belanger, F., and Barbeau, A., 1981, The hypotensive effect of centrally administered neurotensin in rats, Eur. J. Pharmacol. 69:241–247.PubMedCrossRefGoogle Scholar
  205. Rivier, J. E., Lazarus, L. H., Perrin, M. H., and Brown, M. R., 1977, Neurotensin analogues. Structure-activity relationships, J. Med. Chem. 20:1409–1411.PubMedCrossRefGoogle Scholar
  206. Roberts, G. W., Crow, T. J., and Polak, J. M., 1981, Neurotensin: First report of a cortical pathway, Peptides 2(Suppl. l):37–43.PubMedCrossRefGoogle Scholar
  207. Roberts, G. W., Woodhams, P. L., Polak, J. M., and Crow, T. J., 1982, Distribution of neuropeptides in the limbic system of the rat: The amygdala complex, Neuroscience 7:99–131.PubMedCrossRefGoogle Scholar
  208. Rokaeus, A., Fried, G., and Lundberg, J. M., 1984, Occurrence, storage and release of neurotensin-like immunoreactivity from the adrenal gland, Acta Physiol. Scand. 120:373–380.PubMedCrossRefGoogle Scholar
  209. Roques, B. P., Fournie-Zaluski, M. C., Soroca, E., Lecomte, J. H., Malfroy, B., Llorens, C., and Schwartz, J. C., 1980, The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice, Nature 288:286–288.PubMedCrossRefGoogle Scholar
  210. Rossie, S.S., and Miller, R. J., 1982, Regulation of mast cell histamine release by neurotensin, Ann. N.Y. Acad. Sci. 400:394–395.CrossRefGoogle Scholar
  211. Sadoul, J.-L, Kitabgi, P., Rostene, W., Javoy-Agid, F., Agid, Y., and Vincent, J.-P., 1984a, Characterization and visualization of neurotensin binding to receptor sites in human brain, Biochem. Biophys. Res. Commun. 120:206–213.PubMedCrossRefGoogle Scholar
  212. Sadoul, J.-L., Mazella, J., Amar, S., Kitabgi, P., and Vincent, J.-D., 1984b, Preparation of neurotensin selectivity iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors, Biochem. Biophys. Res. Commun. 120:812–819.PubMedCrossRefGoogle Scholar
  213. Sadoul, J.-L., Checler, F., Kitabgi, P., Rostrene, W., Javoy-Agid, F., and Vincent, J.-P., 1984c, Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects, Biochem. Biophys. Res. Commun. 125:395–404.PubMedCrossRefGoogle Scholar
  214. Sawada, S., and Yamamoto, C., 1980, Effects of neurotensin, enkephalin and dopamine on electrical activity of the interstitial nucleus of the stria terminalis, Neurosci. Lett. 17(Suppl. 4):58.Google Scholar
  215. Sawada, S., Takada, S., and Yamamoto, C., 1980, Electrical activity recorded from thin sections of the bed nucleus of the stria terminalis, and the effects of neurotensin, Brain Res. 188:578–581.PubMedCrossRefGoogle Scholar
  216. Schultzberg, M., Hokfelt, T., Nilsson, G., Terenius, L., Rehfield, J. F., Brown, M., Elde, R., Goldstein, M., and Said, S., 1980, Distribution of peptide-and catecholamine-containing neurons in the gastrointestinal tract of rat and guinea pig: Immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin, and dopamine β-hydroxylase, Neuroscience 5:689–744.PubMedCrossRefGoogle Scholar
  217. Seeman, P., 1980, Dopamine receptors, Pharmacol. Rev. 3:229–313.Google Scholar
  218. Shiraishi, T., Inoue, A., and Yanaihara, N., 1980, Neurotensin and bombesin effects on LHA-gas-trosecretory relations, Brain Res. Bull. 4(suppl. 5): 133–142.CrossRefGoogle Scholar
  219. Simpson, W. M., and Varga, E., 1974, Clozapine—a new antipsychotic agent, Curr. Ther. Res. 16:679–686.PubMedGoogle Scholar
  220. Skowsky, R., Smith, P., and Swan, L., 1978, The effects of enkephalins, substance P and neurotensin on arginine vasopressin (AVP) release in the unanesthetized cat, Clin. Res. 26:108A.Google Scholar
  221. Snidjers, R., Kramarcy, N. R., Hurd, R. W., Nemeroff, C. B., and Dunn, A. J., 1982, Neurotensin induces catalepsy in mice, Neuropharmacology 21:465–468.CrossRefGoogle Scholar
  222. Stanley, B. G., Eppel, N., and Noebel, B. G., 1982, Neurotensin injected into the paraventricular hypothalamus suppresses feeding in rats, Ann. N.Y. Acad. Sci. 400:425–427.CrossRefGoogle Scholar
  223. Starr, M. S., 1982, Influence of peptides on 3H-dopamine release from superfused rat striatal slices, Neurochem. Int. 4:233–240.PubMedCrossRefGoogle Scholar
  224. Sundler, F., Hakanson, R., Hammer, R. A., Alumets, J., Carraway, R., Leeman, S. E., and Zimmerman, E. A., 1977, Immunohistochemical localization of neurotensin in endocrine cells of the gut, Cell Tissue Res. 178:313–321.PubMedGoogle Scholar
  225. Suzue, T., Yanaihara, N., and Otsuka, M., 1981, Actions of vasopressin, gastrin releasing peptide and other peptides on neurons of newborn rat spinal cord in vitro, Neurosci. Lett. 26:137–142.PubMedCrossRefGoogle Scholar
  226. Tache, Y., Brown, M. R., and Collu, R., 1979, Effects of neuropeptides on adenohypophyseal hormone response to acute stress in male rats, Endocrinol. 105:220–224.CrossRefGoogle Scholar
  227. Uhl, G. R., and Kuhar, M. J., 1984, Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra, Nature 309:350–352.PubMedCrossRefGoogle Scholar
  228. Uhl, G. R., and Snyder, S. H., 1977a, Regional and subcellular distribution of brain neurotensin, Life Sci. 19:1827–1832.CrossRefGoogle Scholar
  229. Uhl, G. R., and Snyder, S. H., 1977b, Neurotensin receptor binding: Regional and subcellular distributions favor transmitter role, Rue. J. Pharmacol. 41:89–91.Google Scholar
  230. Uhl, G. R., and Snyder, S. H., 1979, Neurotensin: A neuronal pathway projecting from amygdala through stria terminalis, Brain Res. 161:522–526.PubMedCrossRefGoogle Scholar
  231. Uhl, G. R., and Snyder, S. H., 1981, Neurotensin, in: Neurosecretion and Brain Peptides (J. B. Martin, S. Reichlin, and K. L. Bick, eds.), pp. 87–106, Raven Press, New York.Google Scholar
  232. Uhl, G. R., Kuhar, M. J., and Snyder, S. H., 1977a, Neurotensin: Immunohistochemical localization in rat central nervous system, Proc. Natl. Acad. Sci. U.S.A. 74:4059–4063.PubMedCrossRefGoogle Scholar
  233. Uhl, G. R., Bennett, J. P., and Snyder, S. H., 1977b, Neurotensin: A central nervous system peptide; apparent receptor binding in brain membranes, Brain Res. 130:299–313.PubMedCrossRefGoogle Scholar
  234. Uhl, G. R., Goodman, R. R., and Snyder, S. H., 1979, Neurotensin-containing cell bodies, fibers, and nerve terminals in the brainstem of the rat: Immunohistochemical mapping, Brain Res. 167:77–91.PubMedCrossRefGoogle Scholar
  235. Uhl, G. R., Whitehouse, P. J., Price, D. L., Tourtelofte, W. W., and Kuhar, M. J., 1984, Parkinson’s disease: Depletion of substantia nigra neurotensin receptors, Brain Res. 308:186–190.PubMedCrossRefGoogle Scholar
  236. van Wimersma Greidanus, T. B., van Praag, M. C. G., Kalmann, R., Rinkel, G. J. E., Croiset, G., Hoeke, E. C., van Egmond, M. A. H., and Fekete, M., 1982, Behavioral effects of neurotensin, Ann. N.Y. Acad. Sci. 400:319–329.PubMedCrossRefGoogle Scholar
  237. van Wimersma Greidanus, T. J. B., Schijff, J. A., Woteboom, J. L., Spit, M. C., Bruins, L., van Zumberen, M., and Rinkel, J. R., 1984, Neurotensin and bombesin, a relationship between their effects on body temperature and locomotor activity? Pharmacol. Biochem. Behav. 21:197–202.PubMedCrossRefGoogle Scholar
  238. Vijayan, E., and McCann, S. M., 1979, In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release, Endocrinology 105:64–68.PubMedCrossRefGoogle Scholar
  239. Vincent, J. P., Mazella, J., Poustis, C., Checker, F., Kitabgi, P., Labbe, L., Granier, C., and von Rietschoten, J., 1982, Monoido-Trpn-neurotensin, a new ligand to study the interaction of neu-rotensin with its receptor, Ann. N.Y. Acad. Sci. 400:436–437.CrossRefGoogle Scholar
  240. Widdowson, P. S., Griffiths, E. C., Slater, P., and Yajima, H., 1983, Effects of mammalian and avian neurotensins and neurotensin fragments on wet-dog shaking and body temperature in the rat, Reg. Peptides 7:357–365.CrossRefGoogle Scholar
  241. Widerlov, E., Kilts, C. D., Mailman, R. B., Nemeroff, C. B., McCown, T. J., Prange, A. J., Jr., and Breese, G. R., 1982a, Increase in dopamine metabolites in rat brain by neurotensin, J. Pharmacol. Exp. Ther. 222:1–6.Google Scholar
  242. Widerlov, E., Lindstrom, L. H., Besev, G., Manberg, P. J., Nemeroff, C. B., Breese, G. R., Kizer, J. S., and Prange, A. J., Jr., 1982b, Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: Normalization after neuroleptic treatment, Am. J. Psychiatry 139:1122–1126.PubMedGoogle Scholar
  243. Yaksh, T. L., Schmouss, C., Micevych, P. E., Abay, E. O., and Go, V. L. M., 1982, Pharmacological studies on the application, disposition and release of neurotensin in the spinal cord, Ann. N.Y. Acad. Sci. 400:228–243.PubMedCrossRefGoogle Scholar
  244. Young, W. S. III, and Kuhar, M. J., 1979, Neurotensin receptors: Autoradiographic localization in rat CNS, Eur. J. Pharmacol. 59:161–163.PubMedCrossRefGoogle Scholar
  245. Young, W. S. III, and Kuhar, M. J., 1981, Neurotensin receptor localization by light microscopic autoradigraphy in rat brain, Brain Res. 220:273–285.CrossRefGoogle Scholar
  246. Young, W. S., Uhl, G. R., and Kuhar, M. J., 1978, Iontophoresis of neurotensin in the area of the locus coeruleus, Brain Res. 150:431–435.PubMedCrossRefGoogle Scholar
  247. Zieglgansberger, W., Siggins, G., Brown, M., Vale, W., and Bloom, F., 1978, Actions of neurotensin upon single neurone activity in different regions of the rat brain, in: Seventh International Congress on Pharmacology, p. 126, London.Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Peter J. Elliott
    • 1
  • Charles B. Nemeroff
    • 2
  1. 1.Department of PsychiatryDuke University Medical CenterDurhamUSA
  2. 2.Departments of Psychiatry and Pharmacology and Center for Aging and Human DevelopmentDuke University Medical CenterDurhamUSA

Personalised recommendations